LOADING
Comparing Merck & Company (MRK) and PayPal Holdings (PYPL) across the Health Care and Financials sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | MRK | PYPL |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $356.0B | $45.2B |
| P/E Ratio | 116.4 | 10.0 |
| Forward P/E | 15.3 | 9.1 |
| PEG Ratio | 2.71 | 0.93 |
| EPS | $1.24 | $5.26 |
| Revenue Growth (YoY) | 5.1% | 4.8% |
| Profit Margin | 4.8% | 14.4% |
| Return on Equity | 7.0% | 24.5% |
| Dividend Yield | 2.31% | 1.06% |
| Beta | 0.23 | 1.29 |
| 52-Week High | $156.00 | $78.34 |
| 52-Week Low | $79.67 | $38.12 |
| Volume | -- | -- |
Merck & Company is the larger company by market capitalization. PayPal Holdings trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Merck & Company offers a higher dividend yield for income investors. PayPal Holdings has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.